$ALTX
ALTEX INDUSTRIES INC

2024 Q2 Form 10-Q Financial Statement

#000109690624001021 Filed on May 03, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $4.000K $6.000K
YoY Change -33.33% -14.29%
Cost Of Revenue $1.000K $0.00
YoY Change -50.0%
Gross Profit $3.000K $6.000K
YoY Change -25.0% -14.29%
Gross Profit Margin 75.0% 100.0%
Selling, General & Admin $56.00K $64.00K
YoY Change 14.29% 23.08%
% of Gross Profit 1866.67% 1066.67%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $2.000K $1.000K
YoY Change 100.0% 0.0%
% of Gross Profit 66.67% 16.67%
Operating Expenses $59.00K $65.00K
YoY Change 18.0% 22.64%
Operating Profit -$56.00K -$59.00K
YoY Change 21.74% 28.26%
Interest Expense $34.00K $29.00K
YoY Change 25.93% 16.0%
% of Operating Profit
Other Income/Expense, Net $560.0K $29.00K
YoY Change 55900.0% 16.0%
Pretax Income $505.0K -$30.00K
YoY Change -2905.56% 42.86%
Income Tax
% Of Pretax Income
Net Earnings $505.0K -$30.00K
YoY Change -2905.56% 42.86%
Net Earnings / Revenue 12625.0% -500.0%
Basic Earnings Per Share
Diluted Earnings Per Share $0.04 $0.00
COMMON SHARES
Basic Shares Outstanding 11.35M shares 11.35M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.689M $2.194M
YoY Change 19.09% -4.19%
Cash & Equivalents $2.689M $2.194M
Short-Term Investments
Other Short-Term Assets $29.00K $10.00K
YoY Change 0.0% 11.11%
Inventory
Prepaid Expenses
Receivables $3.000K $3.000K
Other Receivables $0.00 $0.00
Total Short-Term Assets $2.721M $2.207M
YoY Change 18.72% -4.21%
LONG-TERM ASSETS
Property, Plant & Equipment $26.00K $27.00K
YoY Change -69.05% -15.63%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $53.00K $61.00K
YoY Change -36.9% -32.97%
TOTAL ASSETS
Total Short-Term Assets $2.721M $2.207M
Total Long-Term Assets $53.00K $61.00K
Total Assets $2.774M $2.268M
YoY Change 16.75% -5.3%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.000K $1.000K
YoY Change 33.33% 0.0%
Accrued Expenses $1.140M $1.140M
YoY Change -2.98% -0.09%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.183M $1.176M
YoY Change 0.42% 0.26%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $0.00 $6.000K
YoY Change -100.0% -81.82%
Total Long-Term Liabilities $0.00 $6.000K
YoY Change -100.0% -81.82%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.183M $1.176M
Total Long-Term Liabilities $0.00 $6.000K
Total Liabilities $1.183M $1.182M
YoY Change -1.83% -1.99%
SHAREHOLDERS EQUITY
Retained Earnings -$12.24M -$12.74M
YoY Change -3.49% 0.63%
Common Stock $114.0K $114.0K
YoY Change -1.72% -1.72%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.591M $1.086M
YoY Change
Total Liabilities & Shareholders Equity $2.774M $2.268M
YoY Change 16.75% -5.3%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income $505.0K -$30.00K
YoY Change -2905.56% 42.86%
Depreciation, Depletion And Amortization $2.000K $1.000K
YoY Change 100.0% 0.0%
Cash From Operating Activities -$30.00K -$25.00K
YoY Change -6.25% 78.57%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $525.0K
YoY Change
Cash From Investing Activities $525.0K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000
YoY Change
NET CHANGE
Cash From Operating Activities -30.00K -25.00K
Cash From Investing Activities 525.0K
Cash From Financing Activities 0.000 0.000
Net Change In Cash 495.0K -25.00K
YoY Change -1646.88% 78.57%
FREE CASH FLOW
Cash From Operating Activities -$30.00K -$25.00K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
1-9030
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
84-0989164
dei Entity Address Address Line1
EntityAddressAddressLine1
700 Colorado Blvd #273
dei Entity Address City Or Town
EntityAddressCityOrTown
Denver
dei Entity Address State Or Province
EntityAddressStateOrProvince
CO
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
80206
dei City Area Code
CityAreaCode
303
dei Local Phone Number
LocalPhoneNumber
265-9312
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
11348021 shares
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2194000 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2232000 usd
CY2024Q1 us-gaap Accounts Receivable Net
AccountsReceivableNet
3000 usd
CY2023Q3 us-gaap Accounts Receivable Net
AccountsReceivableNet
4000 usd
CY2024Q1 us-gaap Other Assets Current
OtherAssetsCurrent
10000 usd
CY2023Q3 us-gaap Other Assets Current
OtherAssetsCurrent
22000 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
2207000 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
2258000 usd
CY2024Q1 us-gaap Proved Oil And Gas Property Successful Effort Method
ProvedOilAndGasPropertySuccessfulEffortMethod
326000 usd
CY2023Q3 us-gaap Proved Oil And Gas Property Successful Effort Method
ProvedOilAndGasPropertySuccessfulEffortMethod
326000 usd
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
299000 usd
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
297000 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
27000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
29000 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
34000 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
47000 usd
CY2024Q1 us-gaap Assets
Assets
2268000 usd
CY2023Q3 us-gaap Assets
Assets
2334000 usd
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
1000 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
4000 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
28000 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
27000 usd
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1140000 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1140000 usd
CY2024Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
7000 usd
CY2023Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
11000 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1176000 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
1182000 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
6000 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
20000 usd
CY2024Q1 us-gaap Liabilities
Liabilities
1182000 usd
CY2023Q3 us-gaap Liabilities
Liabilities
1202000 usd
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11348021 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11348021 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11348021 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11348021 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
114000 usd
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
114000 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
13715000 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
13715000 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-12743000 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-12697000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
1086000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
1132000 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2268000 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2334000 usd
CY2024Q1 us-gaap Results Of Operations Revenue From Oil And Gas Producing Activities
ResultsOfOperationsRevenueFromOilAndGasProducingActivities
6000 usd
CY2023Q1 us-gaap Results Of Operations Revenue From Oil And Gas Producing Activities
ResultsOfOperationsRevenueFromOilAndGasProducingActivities
7000 usd
us-gaap Results Of Operations Revenue From Oil And Gas Producing Activities
ResultsOfOperationsRevenueFromOilAndGasProducingActivities
12000 usd
us-gaap Results Of Operations Revenue From Oil And Gas Producing Activities
ResultsOfOperationsRevenueFromOilAndGasProducingActivities
20000 usd
CY2024Q1 us-gaap Revenues
Revenues
6000 usd
CY2023Q1 us-gaap Revenues
Revenues
7000 usd
us-gaap Revenues
Revenues
12000 usd
us-gaap Revenues
Revenues
20000 usd
CY2024Q1 us-gaap Production Tax Expense
ProductionTaxExpense
0 usd
CY2023Q1 us-gaap Production Tax Expense
ProductionTaxExpense
0 usd
us-gaap Production Tax Expense
ProductionTaxExpense
1000 usd
us-gaap Production Tax Expense
ProductionTaxExpense
1000 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
64000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
52000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
114000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
165000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3000 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
65000 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
53000 usd
us-gaap Operating Expenses
OperatingExpenses
117000 usd
us-gaap Operating Expenses
OperatingExpenses
169000 usd
CY2024Q1 us-gaap Interest Income Other
InterestIncomeOther
29000 usd
CY2023Q1 us-gaap Interest Income Other
InterestIncomeOther
25000 usd
us-gaap Interest Income Other
InterestIncomeOther
59000 usd
us-gaap Interest Income Other
InterestIncomeOther
44000 usd
CY2024Q1 us-gaap Other Income
OtherIncome
0 usd
CY2023Q1 us-gaap Other Income
OtherIncome
0 usd
us-gaap Other Income
OtherIncome
0 usd
us-gaap Other Income
OtherIncome
8000 usd
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
29000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
25000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
59000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
52000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-30000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-21000 usd
us-gaap Net Income Loss
NetIncomeLoss
-46000 usd
us-gaap Net Income Loss
NetIncomeLoss
-97000 usd
CY2024Q1 fil Basic And Diluted Income Loss Per Share
BasicAndDilutedIncomeLossPerShare
-0
CY2023Q1 fil Basic And Diluted Income Loss Per Share
BasicAndDilutedIncomeLossPerShare
-0
fil Basic And Diluted Income Loss Per Share
BasicAndDilutedIncomeLossPerShare
-0
fil Basic And Diluted Income Loss Per Share
BasicAndDilutedIncomeLossPerShare
-0.01
CY2024Q1 fil Basic And Diluted Weighted Average Shares Outstanding
BasicAndDilutedWeightedAverageSharesOutstanding
11348021 shares
CY2023Q1 fil Basic And Diluted Weighted Average Shares Outstanding
BasicAndDilutedWeightedAverageSharesOutstanding
11517426 shares
fil Basic And Diluted Weighted Average Shares Outstanding
BasicAndDilutedWeightedAverageSharesOutstanding
11348021 shares
fil Basic And Diluted Weighted Average Shares Outstanding
BasicAndDilutedWeightedAverageSharesOutstanding
11585280 shares
us-gaap Net Income Loss
NetIncomeLoss
-46000 usd
us-gaap Net Income Loss
NetIncomeLoss
-97000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4000 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-12000 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-17000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-3000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-3000 usd
fil Increase In Accrued Expenses Related Party
IncreaseInAccruedExpensesRelatedParty
0 usd
fil Increase In Accrued Expenses Related Party
IncreaseInAccruedExpensesRelatedParty
68000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-4000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-6000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
0 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-1000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-38000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-23000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
45000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-45000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-38000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-68000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2232000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2358000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2194000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2290000 usd
us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
525000 usd

Files In Submission

Name View Source Status
0001096906-24-001021-index-headers.html Edgar Link pending
0001096906-24-001021-index.html Edgar Link pending
0001096906-24-001021.txt Edgar Link pending
0001096906-24-001021-xbrl.zip Edgar Link pending
altx-20240331.htm Edgar Link pending
altx-20240331.xsd Edgar Link pending
altx_ex31.htm Edgar Link pending
altx_ex32.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
altx-20240331_def.xml Edgar Link unprocessable
altx-20240331_lab.xml Edgar Link unprocessable
altx-20240331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
altx-20240331_htm.xml Edgar Link completed
altx-20240331_cal.xml Edgar Link unprocessable